Cardiac
disease remains the number one cause of all mortality in the United States,
prompting a continued effort to understand the various factors that exacerbate
heart disease. To this end, murine models of cardiac disease have served a
crucial role by allowing researchers to systematically manipulate
disease-linked factors and longitudinally track changes in cardiovascular
function. Routine assessment of heart function in these mice is often conducted
using high-frequency ultrasound; however, cardiac function metrics drawn from
conventional ultrasound imaging heavily relies on measurements obtained from a
representative slice of the heart and idealized geometries of the left
ventricle. While high-field cine-MRI can circumvent these limitations with
volumetric imaging, our group has recently developed and validated a high
frequency four-dimensional ultrasound (4DUS) technique that provides higher
spatiotemporal resolution, comparable accuracy in cardiac metrics, and
relatively faster acquisitions compared to cine-MRI. We have also developed
standardized analysis methods for left-ventricular 4DUS data, encapsulated in a
custom interactive software toolbox. Our software helps users measure
regionally-specific myocardial kinematics, interpolates a four-dimensional mesh
of the endo- and epi-cardial boundaries, and then quantifies various myocardial
strain metrics. We have applied these tools to study disease progression in two
murine models of pathological cardiac hypertrophy (i.e. Cpt2M-/- and Nkx2-5183P/+).
Backed by our demonstrated findings, we aim to provide researchers studying
cardiac disease a more comprehensive approach to characterizing their chosen
models, and increase the scientific reach of cardiovascular research at large.
Funding
Spatial Analysis of Cardiac Disease using Murine Four-Dimensional Ultrasound